Literature DB >> 10818453

Mechanisms of lysolipid phosphate effects on cellular survival and proliferation.

E J Goetzl1, H Lee, H Dolezalova, K R Kalli, C A Conover, Y L Hu, T Azuma, T P Stossel, J S Karliner, R B Jaffe.   

Abstract

The specificity of cellular effects of lysolipid phosphate (LLP) growth factors is determined by binding to endothelial differentiation gene-encoded G protein-coupled receptors (EDG Rs), which transduce diverse proliferative and effector signals. The primary determinants of cellular responses to LLPs are the generative and biodegradative events, which establish steady-state concentrations of each LLP at cell surfaces, and the relative frequency of expression of each EDG R. There are major differences among types of cells in the net effective generation of the LLPs, lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), and in their profile of expression of EDG Rs. The less well characterized secondary determinants of cellular specificity of LLPs are high-affinity binding proteins with carrier and cell-presentation functions, cell-selective regulators of expression of EDG Rs, and cellular factors that govern coupling of EDG Rs to G protein transductional pathways. The roles of components of the LLP-EDG R system in normal physiology and disease processes will be definitively elucidated only after development of animal models with biologically meaningful alterations in genes encoding EDG Rs and the discovery of potent and selective pharmacological probes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818453     DOI: 10.1111/j.1749-6632.2000.tb06549.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Identification of X-linked genes required for migration and programmed cell death of Drosophila melanogaster germ cells.

Authors:  Clark R Coffman; Rachel C Strohm; Fredrick D Oakley; Yukiko Yamada; Danielle Przychodzin; Robert E Boswell
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

2.  GPAT3 and GPAT4 are regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis.

Authors:  Dandan Shan; Jian-liang Li; Leeying Wu; Dongmei Li; Jonathan Hurov; James F Tobin; Ruth E Gimeno; Jingsong Cao
Journal:  J Lipid Res       Date:  2010-02-24       Impact factor: 5.922

Review 3.  Lysophospholipid receptors in the nervous system.

Authors:  Rachelle E Toman; Sarah Spiegel
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

4.  Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.

Authors:  Qingchun Cai; Zhenwen Zhao; Caryl Antalis; Libo Yan; Giuseppe Del Priore; Ali Hassan Hamed; Frederick B Stehman; Jeanne M Schilder; Yan Xu
Journal:  FASEB J       Date:  2012-07-05       Impact factor: 5.191

5.  Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.

Authors:  Larry Pederson; Ming Ruan; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

6.  Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC.

Authors:  Ganchimeg Ishdorj; Bonnie A Graham; Xiaojie Hu; Jing Chen; James B Johnston; Xianjun Fang; Spencer B Gibson
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

Review 7.  Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions.

Authors:  Fang-Tsyr Lin; Yun-Ju Lai
Journal:  Biochim Biophys Acta       Date:  2008-05-03

8.  Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.

Authors:  Sang-Kyung Jo; Amandeep Bajwa; Hong Ye; Amy L Vergis; Alaa S Awad; Yugesh Kharel; Kevin R Lynch; Mark D Okusa
Journal:  Kidney Int       Date:  2008-10-29       Impact factor: 10.612

9.  Sphingosine-1-phosphate stimulates human Caco-2 intestinal epithelial proliferation via p38 activation and activates ERK by an independent mechanism.

Authors:  Vijayalakshmi Thamilselvan; Wei Li; Bauer E Sumpio; Marc D Basson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-04       Impact factor: 2.416

10.  Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.

Authors:  Thomas M McIntyre; Aaron V Pontsler; Adriana R Silva; Andy St Hilaire; Yong Xu; Jerald C Hinshaw; Guy A Zimmerman; Kotaro Hama; Junken Aoki; Hiroyuki Arai; Glenn D Prestwich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.